{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:17:44Z","timestamp":1790201864264,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T00:00:00Z","timestamp":1387411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Parkinson's disease (\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      ) is a common neurodegenerative disease, characterized by progressive loss of dopaminergic (\n                      <jats:styled-content style=\"fixed-case\">DA<\/jats:styled-content>\n                      ) neurons in the substantia nigra. Recent investigations have shown that mitochondrial fragmentation, an early event during apoptosis, is implicated in the degeneration of\n                      <jats:styled-content style=\"fixed-case\">DA<\/jats:styled-content>\n                      neurons in\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      , and more importantly, preventing mitochondrial fragmentation could rescue cell death in several\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      models. Therefore, mitochondrial dynamics may be a therapeutic target for early intervention in\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      . However, much remains unknown about the mechanism underlying mitochondrial fragmentation in\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The alterations in mitochondrial morphology, cell apoptosis, and mitochondrial shaping protein levels were detected after\n                      <jats:styled-content style=\"fixed-case\">SH<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">SY<\/jats:styled-content>\n                      5Y cells were treated with various doses of\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      + or rotenone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mitochondrial fragmentation is an early event during apoptosis caused by\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      + but not rotenone, and Trichostatin A (\n                      <jats:styled-content style=\"fixed-case\">TSA<\/jats:styled-content>\n                      ), a commonly used histone deacetylase (\n                      <jats:styled-content style=\"fixed-case\">HDAC<\/jats:styled-content>\n                      ) inhibitor, selectively rescues mitochondrial fragmentation and cell death induced by lower doses of\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      +. Mitochondrial fragmentation triggered by lower doses of\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      + may be a result of Mfn2 down\u2010regulation, which could be completely reversed by\n                      <jats:styled-content style=\"fixed-case\">TSA<\/jats:styled-content>\n                      . Further investigation suggests that\n                      <jats:styled-content style=\"fixed-case\">TSA<\/jats:styled-content>\n                      prevents\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      +\u2010induced Mfn2 down\u2010regulation via inhibiting histone deacetylation over\n                      <jats:italic>Mfn2<\/jats:italic>\n                      promoter and alleviating its transcriptional dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Histone deacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection in\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      cell model induced by\n                      <jats:styled-content style=\"fixed-case\">MPP<\/jats:styled-content>\n                      +. Hence,\n                      <jats:styled-content style=\"fixed-case\">HDAC<\/jats:styled-content>\n                      inhibitors may be a potential early treatment for\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cns.12217","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T03:02:07Z","timestamp":1387422127000},"page":"308-316","source":"Crossref","is-referenced-by-count":52,"title":["Histone Decacetylase Inhibitors Prevent Mitochondrial Fragmentation and Elicit Early Neuroprotection against\n                    <scp>MPP<\/scp>\n                    +"],"prefix":"10.1111","volume":"20","author":[{"given":"Min","family":"Zhu","sequence":"first","affiliation":[{"name":"Laboratory of Neurology of Integrative Medical Institute Zhongshan Hospital Fudan University Shanghai China"},{"name":"Department of Neurology Institute of Neurology Huashan Hospital Fudan University Shanghai China"},{"name":"The State Key Laboratory of Neurobiology Shanghai Medical College Fudan University Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen\u2010Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Neurology of Integrative Medical Institute Zhongshan Hospital Fudan University Shanghai China"},{"name":"Department of Neurology Institute of Neurology Huashan Hospital Fudan University Shanghai China"},{"name":"Institutes of Brain Science Fudan University Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan\u2010Zhen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurology Institute of Neurology Huashan Hospital Fudan University Shanghai China"},{"name":"The State Key Laboratory of Neurobiology Shanghai Medical College Fudan University Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,19]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0435-2"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2012.10.006"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi270"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1658508"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2012.07769.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2012.07734.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2011.00721.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601253"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402087"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709336105"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036377"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5379-10.2011"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M407384200"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2009.03.006"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200209124"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200309082"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb955"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb11409.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfl125"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044610"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200211046"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408910200"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501599200"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds311"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37829"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.02282-05"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402107"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05111"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402046"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2007.12.002"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.06.002"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.01.011"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.10.037"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.01.026"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcns.12217","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.12217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T12:39:44Z","timestamp":1695559184000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.12217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1111\/cns.12217"],"URL":"https:\/\/doi.org\/10.1111\/cns.12217","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,19]]}}}